A new experimental drug developed to target HPV-related cervical disease could transform the way stage 0 cervical cancer and precancerous...
New Drug for Stage 0 Cervical Cancer May Reduce Need for Surgery, Says ICMR
In: Anti-HPV therapy, Cancer research, Cancer treatment breakthrough, Carcinoma in situ, Cervical cancer awareness, Cervical cancer India, Cervical cancer prevention, Cervical cancer screening, Cervical cancer treatment, Cervical intraepithelial neoplasia, Cervical lesions, CIN, Clinical trials, Emcure Pharmaceuticals, Gardasil-4, health news India, HPV, HPV drug, HPV infection, HPV vaccine, HPV-related cancer, ICMR, Medical research, New cervical cancer drug, NICPR, Non-surgical cervical cancer treatment, Oncology, Precision medicine, preventive healthcare, SHetA2, Stage 0 cancer, Stage 0 cervical cancer, Targeted therapy, University of Oklahoma, Women's health